About this Journal Submit a Manuscript Table of Contents
Stroke Research and Treatment
Volume 2011 (2011), Article ID 735057, 3 pages
http://dx.doi.org/10.4061/2011/735057
Case Report

Intravenous Thrombolysis of Occlusion in the Middle Cerebral and Retinal Arteries from Presumed Ventricular Myxoma

1Department of Neurology, Chia-Yi Christian Hospital, 539 Chung-Shao Road, Chia-Yi 60002, Taiwan
2Department of Physical Therapy, Shu Zen College of Medicine and Management, Kaohsiung, Taiwan
3Department of Cardiology, Chia-Yi Christian Hospital, 539 Chung-Shao Road, Chia-Yi 60002, Taiwan

Received 30 July 2010; Accepted 8 November 2010

Academic Editor: Halvor Naess

Copyright © 2011 Cheung-Ter Ong and Rei-Yeuh Chang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background. Although thrombolytic therapy has been shown to be beneficial to stroke patients, the effectiveness of intravenous thrombolysis in ischemic stroke patients with ventricle myxoma is unknown. Case Description. A 22-year-old woman with left hemiplegia was sent to the emergency department at a teaching hospital. The magnetic resonance angiography showed occlusion of the right middle cerebral artery, and the echocardiography showed a mass in the left ventricle. Intravenous recombined tissue plasminogen activator (rt-PA) was administrated, and the postthrombolysis transcranial Doppler exam showed that her right middle cerebral artery was circulative. The patient's condition improved gradually, and no complication was observed up to 16 months of follow-up. Conclusion. Intravenous rt-PA is a reasonable treatment for stroke patients with ventricle myxoma.